Literature DB >> 6870221

Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route.

J Mattila, P T Männistö, R Mäntylä, S Nykänen, U Lamminsivu.   

Abstract

Serum kinetics of metronidazole and tinidazole were compared in four separate randomized crossover studies. Single doses of each drug were given to healthy volunteers through intravenous infusion (500 mg over 20 min, six persons), by mouth (500 mg, nine persons), by rectum (1,000 mg, six persons), or intravaginally (500 mg, six persons). Concentrations of the unchanged drugs in serum, measured by high-pressure liquid chromatography, were similar after oral and intravenous administration, with mean peaks of 9.0 and 9.4 micrograms/ml for metronidazole and 7.5 and 10.1 micrograms/ml for tinidazole. Concentrations of tinidazole were significantly higher than those of metronidazole from 4 h onwards after intravenous infusion, and from 3 h onwards after administration by mouth. After rectal administrations, a significant difference was seen only at 48 h. After vaginal dosing, however, concentrations of metronidazole were significantly higher than those of tinidazole between 1.5 and 12 h. Bioavailability of either drug, calculated according to the formula (area under the curve for oral administration)/(area under the curve for infusion), was practically complete after oral administration and was poorer after rectal and especially vaginal administration. Whenever the parameters were calculable, the elimination half-life of tinidazole (range of means, 14.0 to 14.7 h) was significantly longer and total clearance (40.3 to 47.6 ml/min) was lower than the corresponding values of metronidazole (7.9 to 8.8 h and 71.8 to 80.1 ml/min, respectively).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870221      PMCID: PMC184797          DOI: 10.1128/AAC.23.5.721

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses.

Authors:  B A Wood; A M Monro
Journal:  Br J Vener Dis       Date:  1975-02

2.  The pharmacokinetics of metronidazole and tinidazole in man.

Authors:  P G Welling; A M Monro
Journal:  Arzneimittelforschung       Date:  1972-12

3.  Determination of metronidazole and misonidazole and their metabolites in plasma and urine by high-performance liquid chromatography.

Authors:  R A Marques; B Stafford; N Flynn; W Sadée
Journal:  J Chromatogr       Date:  1978-07-01

4.  The pharmacokinetics of intravenous tinidazole in man.

Authors:  C Charuel; J Nachbaur; A M Monro; J De Palol
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

5.  Rectal administration of metronidazole provides therapeutic plasma levels in postoperative patients.

Authors:  L Ioannides; A Somogyi; J Spicer; B Heinzow; N Tong; C Franklin; A McLean
Journal:  N Engl J Med       Date:  1981-12-24       Impact factor: 91.245

6.  Pharmacokinetics of metronidazole in healthy adult volunteers after tablets and suppositories.

Authors:  T Bergan; E Arnold
Journal:  Chemotherapy       Date:  1980       Impact factor: 2.544

7.  Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose.

Authors:  G W Houghton; P S Thorne; J Smith; R Templeton; J Collier
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

8.  Pharmacokinetics of intravenous metronidazole in man.

Authors:  C Gjerløff; E Arnold
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-08

Review 9.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

10.  Concentrations of tinidazole in body fluids and tissues in gynaecological patients.

Authors:  T Ripa; L Weström; P A Mårdh; K E Andersson
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

View more
  21 in total

1.  Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori.

Authors:  Margareta Svensson; Lennart E Nilsson; Magnus Ström; Maud Nilsson; Mikael Sörberg
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Penetration of tinidazole into skin blister fluid following its oral administration.

Authors:  A Klimowicz; A Nowak; S Bielecka-Grzela
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.

Authors:  Judith M Wenisch; Daniela Schmid; Hung-Wei Kuo; Franz Allerberger; Verena Michl; Philip Tesik; Gerhard Tucek; Hermann Laferl; Christoph Wenisch
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 4.  Treatment Strategies for Recurrent Clostridium difficile Infection.

Authors:  Christine Leong; Sheryl Zelenitsky
Journal:  Can J Hosp Pharm       Date:  2013-11

5.  Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration.

Authors:  P Männistö; M Karhunen; J Mattila; O Koskela; A M Suikkari; P Heinonen; R Tuimala; H Haataja
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

Review 6.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Plasma metronidazole concentrations after single and repeated vaginal pessary administration.

Authors:  I G Salas-Herrera; M Lawson; A Johnston; P Turner; D M Gott; M J Dennis
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 8.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

Review 9.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

10.  Guidelines for the treatment of bacterial vaginosis: focus on tinidazole.

Authors:  Laura J Dickey; Michael D Nailor; Jack D Sobel
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.